175 related articles for article (PubMed ID: 35885447)
1. Long-Standing Lambert-Eaton Myasthenic Syndrome Caused by Undetectable Small-Cell Lung Cancer: Why We Should Follow-Up LEMS.
Hong BY; An HJ; Lim SH
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885447
[TBL] [Abstract][Full Text] [Related]
2. SOX-1 antibodies positive Lambert-Eaton myasthenic syndrome with occult small cell lung cancer: A case report.
Zhao L; He H; Han W; Meng Y; Kang L; Chen Y
Clin Respir J; 2024 Mar; 18(3):e13740. PubMed ID: 38497229
[TBL] [Abstract][Full Text] [Related]
3. Cancer detection after a 9-year course of Lambert-Eaton myasthenic syndrome complicated by anti-Hu associated limbic encephalitis.
Falso S; Spagni G; Iorio R; Evoli A
Neuromuscul Disord; 2023 Sep; 33(9):90-92. PubMed ID: 37507235
[TBL] [Abstract][Full Text] [Related]
4. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer.
Liu Y; Xi J; Zhou L; Wu H; Yue D; Zhu W; Lin J; Lu J; Zhao C; Qiao K
J Clin Neurosci; 2019 Jul; 65():41-45. PubMed ID: 31072737
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
7. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
8. Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.
Zhang RR; Han T; Guo F; Liu ZZ; Han YL; Chen WC; Liu YY; Xie XD
Oncol Lett; 2015 Sep; 10(3):1339-1342. PubMed ID: 26622673
[TBL] [Abstract][Full Text] [Related]
9. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and differential diagnosis of Lambert-Eaton myasthenic syndrome.
Wu X; Wang J; Liu Y; Liu K
Neurosciences (Riyadh); 2013 Apr; 18(2):169-72. PubMed ID: 23545618
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome.
Ishibashi N; Tabata T; Nonomura R; Oshima Y; Sasaki T; Mitomo H; Sugawara T; Sagawa M
Respir Med Case Rep; 2024; 47():101974. PubMed ID: 38374927
[TBL] [Abstract][Full Text] [Related]
12. Unusual paraneoplastic syndromes in pancreatic cancer: a case report of Lambert-Eaton myasthenic syndrome (LEMS) associated with intraductal papillary mucinous cancer of the pancreas.
Zamparas A; Herzog T; Förster S; Siglienti I; Uhl W; Strotmann J; Höhn P
AME Case Rep; 2023; 7():35. PubMed ID: 37942046
[TBL] [Abstract][Full Text] [Related]
13. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
14. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.
Wang S; Bruzzi J; Rodriguez-Garza VP; Komaki RR
Clin Lung Cancer; 2006 Jan; 7(4):282-4. PubMed ID: 16512985
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H
Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415
[TBL] [Abstract][Full Text] [Related]
16. A case of Lambert-Eaton myasthenic syndrome associated with atypical bronchopulmonary carcinoid tumor.
Lee JH; Shin JH; Kim DS; Jung DS; Park KH; Lee MK; Kim JY
J Korean Med Sci; 2004 Oct; 19(5):753-5. PubMed ID: 15483357
[TBL] [Abstract][Full Text] [Related]
17. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
18. [Lambert-Eaton myasthenic syndrome--a rare manifestation of paraneoplastic syndrome in ovarian cancer--case report].
Zivaljević M; Popović S; Vujkov T
Med Pregl; 2005; 58(9-10):495-7. PubMed ID: 16526254
[TBL] [Abstract][Full Text] [Related]
19. [Lambert-Eaton myasthenic syndrome].
Motomura M; Fukuda T
Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
[TBL] [Abstract][Full Text] [Related]
20. Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer.
Yamazoe M; Hatakeyama T; Furukawa K; Kato K; Horiuchi K
Cureus; 2023 Jan; 15(1):e33557. PubMed ID: 36779131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]